Cara Therapeutics
CARA
#10332
Rank
A$2.61 M
Marketcap
$0.57
Share price
-6.08%
Change (1 day)
-32.92%
Change (1 year)

Cara Therapeutics (CARA) - Cash on Hand

Cash on Hand as of September 2024 : A$67.64 Million

According to Cara Therapeutics 's latest financial reports the company has A$67.64 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cara Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.14 B-30.78%
2022-12-31A$0.21 B-7.26%
2021-12-31A$0.23 B-2.08%
2020-12-31A$0.23 B6.28%
2019-12-31A$0.22 B-3.36%
2018-12-31A$0.22 B93.2%
2017-12-31A$0.11 B46.66%
2016-12-31A$80.84 M-44.82%
2015-12-31A$0.14 B127.7%
2014-12-31A$64.34 M364.5%
2013-12-31A$13.85 M1188.85%
2012-12-31A$1.07 M-73.1%
2011-12-31A$3.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$21.66 M-67.98%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.09 M-77.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.01 B 23,574.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.66 B 48,184.80%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.06 M-77.72%๐Ÿ‡บ๐Ÿ‡ธ USA